Hormonal Therapy · FDA-approved (multiple esters) · Weekly to biweekly
Testosterone Injections
Injectable testosterone (cypionate or enanthate) is the most established and typically least expensive form of TRT. There’s a real, evidence-backed choice within injections worth understanding: subcutaneous vs. intramuscular administration produce genuinely different hormone patterns — not just a difference in needle depth.
Overview
Cypionate vs. enanthate — less different than you’d think
Testosterone cypionate and testosterone enanthate are both esterified forms of testosterone dissolved in oil, with nearly identical half-lives (roughly 7–9 days) and clinical kinetics — peak levels within a few days, returning to baseline by about 10–14 days. The real-world difference between them mostly comes down to the carrier oil (cottonseed for cypionate, sesame for enanthate), which can affect injection comfort more than the ester itself affects hormone levels.
Both are FDA-approved and produce clinically equivalent results when dosed appropriately. If you tolerate one well and your levels are stable, there’s little reason to switch to the other based on the ester alone.
The more clinically meaningful decision isn’t cypionate vs. enanthate — it’s intramuscular vs. subcutaneous injection technique, which genuinely does produce different hormone patterns (see below).
A real comparative study
Subcutaneous vs. intramuscular — the actual data
A dual-institutional study compared 263 hypogonadal men treated with either intramuscular testosterone cypionate (the conventional approach) or a subcutaneous testosterone enanthate autoinjector, designed specifically for a lower peak-to-trough ratio (1.8) than typical IM injection.
Neither method was associated with a significant rise in PSA. The practical takeaway: subcutaneous injection with a lower peak-to-trough profile appears to produce steadier levels with less of the hematocrit and estradiol elevation that intramuscular injection’s sharper peaks can cause — a real, measurable safety advantage worth discussing with your provider, particularly if you’ve had issues with elevated hematocrit on IM injections.
How it compares
Injection vs. gel vs. pellet
| Feature | Injection (this page) | Gel | Pellet |
|---|---|---|---|
| Frequency | Weekly to biweekly | Daily | Every 3–6 months |
| Transfer risk to others | None | Yes — real risk | None |
| Level stability | Peak-and-trough (less so with subQ) | Steady, daily peaks | Steady over months |
| Typical cost | Lowest of the common options | Higher | Moderate — requires procedure |
| Adjustable mid-cycle | Yes — change dose or frequency | Yes — daily dose adjustment | No — fixed until pellets dissolve |
Common questions
Frequently asked questions
Is cypionate better than enanthate, or vice versa?
Not meaningfully. Both esters have nearly identical half-lives and produce clinically equivalent testosterone levels when dosed properly. The main practical difference is the carrier oil, which can affect injection site comfort — cottonseed oil (cypionate) is generally thinner and causes less post-injection pain than sesame oil (enanthate) for some men.
Is subcutaneous injection actually better than intramuscular?
A real comparative study found subcutaneous enanthate produced 14% greater trough testosterone levels alongside 41% lower hematocrit and 26.5% lower estradiol compared to intramuscular cypionate — likely because subcutaneous delivery avoids the sharp hormone peaks that intramuscular injection can produce. This makes it a genuinely reasonable option to discuss with your provider, particularly if you’ve experienced elevated hematocrit on IM injections.
Is there an FDA-approved subcutaneous injection option?
Yes — Xyosted® is an FDA-approved subcutaneous testosterone enanthate autoinjector, designed with the lower peak-to-trough profile discussed above. Compounded testosterone enanthate can also be injected subcutaneously using insulin syringes under a provider’s guidance.
Related
Other TRT delivery methods
Find a TRT provider
Search our directory of vetted physicians offering testosterone replacement therapy — or ask in the forum to hear from men who have been through it.
Key sources: “Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate,” Journal of Urology · Nankin, “Hormone kinetics after intramuscular testosterone cypionate,” Fertility and Sterility (1987)
This page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Testosterone is a Schedule III controlled substance requiring a valid prescription and a documented diagnosis. Always consult a licensed physician before pursuing any treatment. PhallusMD does not endorse specific providers or products.
There are no reviews yet. Be the first one to write one.